`
`FDA Home3 Drug Databases‘ Drugs@FDA5
`
`FDA Approved Drug Products
`
`Start Over
`
`Back to Search Results
`
`Drug Details
`
`Drug Name(s)
`FDA Application No.
`Active Ingredient(s)
`Company
`Original Approval or Tentative Approval Date
`Chemical Type
`Review Classification
`
`FAQ5 |
`
`Instructions7 | Glossary3 | Contact us-9
`
`Eemaii Link
`
`DITROPAN XL
`(NDA) 020897
`OXYBUTYNIN CHLORIDE
`JANSSEN PHARMS
`December 16, 1998
`3 New dosage form
`S Standard review drug
`
`- Therapeutic Equivalents
`
`- Label Information
`
`- Approval History, Letters, Reviews, and Related
`Documents
`
`Products on Application (NDA) #020897
`Click on a column header to re-sort the table:
`
`Drug Name
`
`Active Ingredients
`
`Strength Dosage Form] Route
`
`DITROPAN XL
`DITROPAN XL
`DITROPAN XL
`
`OXYBUTYNIN CHLORIDE
`OXYBUTYNIN CHLORIDE
`OXYBUTYNIN CHLORIDE
`
`SMG
`10MG
`1SMG
`
`TABLET, EXTENDED RELEASE;ORAL
`TABLET, EXTENDED RELEASE;ORAL
`TABLET, EXTENDED RELEASE;ORAL
`
`Marketing
`Status
`Prescription
`Prescription
`Prescription
`
`RLD TE
`Code
`No AB
`No AB
`Yes AB
`
`Back to Top | Back to Previous Page | Back to Drugs@FDA Home
`
`Disclaimerlo
`
`FDA/Center for Drug Evaluation and Research
`Office of Communications
`Division of Online Communications
`Update Frequency: Daily
`
`Links on this page:
`
`. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`
`. http://www.addthis.com/bookmark.php
`
`. http://www.fda.gov/default.htm
`
`. http://www.fda.gov/DrugsflnformationOnDrugs/default.htm
`
`. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm
`
`. http://www.fda.gov/Drugs/InformationOnDrugs/ucmO75234.htm
`
`. http://www.fda.gov/Drugs/InformationOnDrugs/UCM079874
`
`. http://www.fda.gov/Drugs/InformationOnDrugs/ucm079436.htm
`
`. http://www.accessdata.fda.gov/scripts/emaiI/cder/commentdrugcat.cfm
`
`. http ://www.fda.gov/AboutFDA/AboutThisWebsite/Website Policies/default. htm#web
`
`\DCO'*~JO\Ll'|-lhLul\Ji-|
`
`l-‘ 9
`
`Patent Owner, UCB Pharma GmbH — Exhibit 2067 - 0001
`
`
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
`
`Accessibility Contact FDA Careers FDA Basics FOIA No FEAR Act Site Map Transparency Website Policies
`
`FDA
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1—888—INFO—FDA (1—888—463—6332)
`Contact FDA
`
`D I3 .1;
`T":~'_._\_.op_v._
`For Government For Press
`
`.9-.
`
`Combination Products Advisory Committees Science & Research Regulatory Information Safety Emergency Preparednes:
`International Programs News & Events Training and Continuing Education Inspections/Compliance State & Local Officials
`Consumers Industry Health Professionals FDA Archive
`fl U.S.Departrnent of Health & Human Services
`
`Links on this page:
`
`. http://www.addthis.com/bookmark.php?uS08=true&v=1S2&username=fdamain
`
`k.DCO'-JO'1U'l-lhLu|\Jl-*
`
`l-‘ 0
`
`. http://www.addthis.com/bookmark.php
`
`. http://www.fda.gov/default.htm
`
`. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`
`. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm
`
`. http://www.fda.gov/Drugs/InformationOnDrugs/ucm075234.htm
`
`. http://www.fda.gov/Drugs/InformationOnDrugs/UCM079874
`
`. http://www.fda.gov/Drugs/InformationOnDrugs/ucm079436.htm
`
`. http://www.accessdata.fda.gov/scripts/emaiI/cder/commentdrugcat.cfm
`
`. http ://www.fda.gov/AboutF DA/AboutThisWebsite/Website Policies/default. htm#web
`
`Patent Owner, UCB Pharma GmbH — Exhibit 2067 - 0002